课题基金 / 基金详情

Discovery of novel broad-spectrum coronavirus inhibitors

Discovery of novel broad-spectrum coronavirus inhibitors
新型广谱冠状病毒抑制剂的发现
批准号:
10845862
负责人:
VINEET D MENACHERY
金额:
$79.83万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-16 至 2025-04-30

项目摘要

项目成果

VINEET D MENACHERY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT 2 – ABSTRACT The goal of this project is to discover novel broad-spectrum coronavirus inhibitors. We will identify new broad- spectrum coronavirus inhibitors of viral replication using a cell-based approach. We will achieve the goal by pursuing three aims. (i) Screen and identify novel compounds for broad-spectrum coronavirus inhibition. We will screen and identify inhibitors of viral replication using SARS-CoV-2, MERS-CoV, and 229E infection assays. UTMB has developed an single-cycle infection system for SARS-CoV-2 that can be used for HTS campaign at BSL2. In this application, we will expand this system to MERS-CoV. We will also develop a reporter 229E coronavirus for antiviral screen. (ii) Develop tool compounds, determine target protein, and optimize molecules. (iii) Evaluate lead compounds in relevant in vitro and in vivo models and select Development Candidate for IND- enabling studies. The proposed cell-based approach may discover novel antiviral targets that may not be tractable for target-based antiviral approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
Administrative Core
Discovery of novel broad-spectrum coronavirus inhibitors
Identifying host and viral correlates for coronavirus pathogenesis
海外基金